VKTX
Viking Therapeutics Inc
36.80$
-11.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.4% | 98.5% | 96.1% | 98.8% | 99.9% | 99.7% | 99.8% | 99.9% | 99.1% | 99.7% | 99.9% | 100.0% | |
| 24.8% | 5.0% | 21.2% | 40.6% | 8.2% | 2.9% | 11.4% | 12.5% | 21.7% | 15.1% | 2.9% | 23.2% | |
| 24.8% | 91.4% | 90.5% | 93.0% | 99.7% | 97.0% | 96.8% | 95.9% | 92.3% | 98.3% | 99.4% | 98.6% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | 0.2% | 0.1% | 0.0% | 0.8% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 827.2% | 43.5% | 44.7% | 39.1% | 1.5% | 2.5% | 4.7% | 4.2% | 13.8% | 5.4% | 3.1% | 10.7% | |
| 739.9% | 12.8% | 44.6% | 39.1% | 1.5% | 2.4% | 4.7% | 4.2% | 13.0% | 5.2% | 3.0% | 10.7% | |
| 10.0% | 13.9% | 22.5% | 15.6% | – | 0.1% | 0.1% | 0.0% | 0.2% | 0.1% | 0.1% | 0.0% | |
| 60.2% | 3.8% | 8.3% | 6.9% | 0.3% | 0.9% | 1.6% | 0.7% | 5.1% | 2.0% | 1.1% | 7.4% | |
| 41.5% | 13.9% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| -727.2% | 56.5% | 55.3% | 60.9% | 98.5% | 97.5% | 95.3% | 95.8% | 86.2% | 94.6% | 96.9% | 89.3% | |
| -727.6% | -295.0% | -414.7% | -365.5% | -34.0% | -45.3% | -65.6% | -105.9% | -173.3% | -102.6% | -53.7% | -118.4% | |
| 141.6% | 41.2% | 112.0% | 117.4% | 19.0% | 25.3% | 28.3% | 36.6% | 45.6% | 25.6% | 12.0% | 15.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.